Digest Network Come funziona
Network
/
Società
Gu
Non verificato

Guardant Health, Inc.

Di cosa scriviamo

BiotecnologiaIndustriaOncologiaSaluteSanità

122 comunicati stampa

Guarda tutti i comunicati
11/06/2026
Industria
Biotecnologia
Farmaceutica
Oncologia
Salute
Igiene alimentare
Attrezzature medico-sanitarie
Sanità
Guardant Health Announces FDA Approval of Guardant360 CDx as Companion Diagnostic for Boehringer Ingelheim’s HERNEXEOS®
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
28/05/2026
Eventi
Industria
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Oncologia
Attrezzature medico-sanitarie
Scienza
Medicina - Varie
Guardant Health and Collaborators to Present 38 Abstracts Highlighting Breadth and Expanded Clinical Utility of Guardant Liquid Biopsy Tests Powered by InfinityAI at 2026 ASCO Annual Meeting
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
27/05/2026
Industria
Tecnica
Igiene alimentare
Associazioni/Professionisti
Software
Salute
Sanità
Oncologia
American Cancer Society Recommends Guardant Health’s Shield Blood Test in Updated Colorectal Cancer Screening Guidelines
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
20/05/2026
Oncologia
Attrezzature medico-sanitarie
Igiene alimentare
Salute
Biotecnologia
Industria
FDA Approves New Guardant360 Liquid CDx, the Largest FDA-Approved Liquid Biopsy Panel with a 100x Expanded Footprint
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
18/05/2026
Cardiologia
Biotecnologia
Oncologia
Salute
Information Technology
Tecnica
Mercato azionario
Finanza
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
07/05/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Oncologia
Attrezzature medico-sanitarie
Salute
Farmaceutica
Biotecnologia
Guardant Health Reports First Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
04/05/2026
Industria
Biotecnologia
Farmaceutica
Oncologia
Salute
Information Technology
Tecnica
Guardant Health Receives FDA Approval for Guardant360® CDx as a Companion Diagnostic for Arvinas and Pfizer’s VEPPANU (vepdegestrant) for Patients with ER+/HER2- Advanced Breast Cancer with ESR1 Mutations
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
30/04/2026
Mercato del lavoro
Industria
Oncologia
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity™ Platform
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
29/04/2026
Web e Social Network
Eventi
Fiere
Biotecnologia
Farmaceutica
Salute
Oncologia
Guardant Health to Participate in Upcoming Investor Conferences
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
16/04/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Attrezzature medico-sanitarie
Salute
Oncologia
Guardant Health to Report First Quarter 2026 Financial Results on May 7, 2026
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0